These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
158 related articles for article (PubMed ID: 24374685)
21. Left ventricular assist device-related infections: does the time of onset matter? Lehnert AL; Hart A; Brouse SD; Charnigo RJ; Branam S; Guglin ME J Artif Organs; 2019 Jun; 22(2):98-103. PubMed ID: 30386926 [TBL] [Abstract][Full Text] [Related]
22. Current concepts in the diagnosis and management of left ventricular assist device infections. Nienaber J; Wilhelm MP; Sohail MR Expert Rev Anti Infect Ther; 2013 Feb; 11(2):201-10. PubMed ID: 23409825 [TBL] [Abstract][Full Text] [Related]
23. Minimum inhibitory concentration changes in relapsed left ventricular assist device driveline infections. Lines TH; Sabato LA; Nesbitt WJ; Moretz JD; Brinkley DM; Satyanarayana G Int J Artif Organs; 2020 Jul; 43(7):494-499. PubMed ID: 31964206 [TBL] [Abstract][Full Text] [Related]
24. Infectious complications in patients with left ventricular assist device: etiology and outcomes in the continuous-flow era. Topkara VK; Kondareddy S; Malik F; Wang IW; Mann DL; Ewald GA; Moazami N Ann Thorac Surg; 2010 Oct; 90(4):1270-7. PubMed ID: 20868826 [TBL] [Abstract][Full Text] [Related]
25. Low Incidence of Pump-Related Infections in Jarvik 2000 Ventricular Assist Device Recipients with a Subcostal Driveline Exit Site. Letsou GV; Anand J; Ogburn E; Shah RM; Ganapathy AV; Cohn WE; Loor G; Frazier OH Tex Heart Inst J; 2019 Jun; 46(3):179-182. PubMed ID: 31708699 [TBL] [Abstract][Full Text] [Related]
27. Prevention of percutaneous driveline infection after left ventricular assist device implantation: prophylactic antibiotics are not necessary. Stulak JM; Maltais S; Cowger J; Joyce LD; Daly RC; Park SJ; Aaronson KD; Pagani FD ASAIO J; 2013; 59(6):570-4. PubMed ID: 24172262 [TBL] [Abstract][Full Text] [Related]
28. Over 870 days of successful antibiotic suppression therapy for VRE-infected left ventricular assist device. Radcliffe C; Grant M J Card Surg; 2020 Jul; 35(7):1746-1748. PubMed ID: 32557822 [TBL] [Abstract][Full Text] [Related]
29. Clinical outcomes associated with chronic antimicrobial suppression therapy in patients with continuous-flow left ventricular assist devices. Jennings DL; Chopra A; Chambers R; Morgan JA Artif Organs; 2014 Oct; 38(10):875-9. PubMed ID: 24571683 [TBL] [Abstract][Full Text] [Related]
30. Cardiac implantable electronic device removal in patients with left ventricular assist device associated infections. Krishnamoorthy A; Pokorney SD; Lewis RK; Daubert JP; Greenfield RA; Hegland DD; Milano CA; Rogers JG; Schroder JN; Patel CB; Piccini JP J Cardiovasc Electrophysiol; 2014 Nov; 25(11):1199-205. PubMed ID: 24890850 [TBL] [Abstract][Full Text] [Related]
31. Ceftolozane/tazobactam for the treatment of MDR Pseudomonas aeruginosa left ventricular assist device infection as a bridge to heart transplant. Peghin M; Maiani M; Castaldo N; Givone F; Righi E; Lechiancole A; Sartor A; Pea F; Livi U; Bassetti M Infection; 2018 Apr; 46(2):263-265. PubMed ID: 29086895 [TBL] [Abstract][Full Text] [Related]
32. Omental and deep inferior epigastric artery perforator flap coverage after heart transplantation to manage wide left ventricular assist device exposure with pocket infection. Inatomi Y; Kadota H; Kaku K; Sonoda H; Tanoue Y; Shiose A J Artif Organs; 2018 Dec; 21(4):466-470. PubMed ID: 30349955 [TBL] [Abstract][Full Text] [Related]